share_log

Leerink Partners Downgrades Q32 Bio to Market Perform, Lowers Price Target to $9

Leerink Partners Downgrades Q32 Bio to Market Perform, Lowers Price Target to $9

Leerink Partners将Q32 Bio评级下调至市场表现,并将目标价下调至9美元
Benzinga ·  12/11 19:57  · 评级/大行评级

Leerink Partners analyst Thomas Smith downgrades Q32 Bio (NASDAQ:QTTB) from Outperform to Market Perform and lowers the price target from $68 to $9.

Leerink Partners分析师Thomas Smith将Q32 Bio(纳斯达克:QTTB)的评级从超越市场下调至市场表现,并将目标价格从68美元下调至9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发